CIK 0001468929
- Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264042544
- Phone
- +1 215-702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 4 Open-market buy Director bought 11,848 shares at $2.11 ($24,999)
- 4 Open-market buy Chief Financial Officer bought 47,394 shares at $2.11 ($100,001)
- 4 Open-market buy Director bought 3,885 shares at $2.20 ($8,535)
- 4 Open-market buy Director bought 2,500 shares at $1.96 ($4,900)
- 4 Open-market buy Director bought 10,500 shares at an average $2.26 ($23,750)
- 4 Open-market buy Director bought 2,980 shares at an average $1.94 ($5,782)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,558 shares at $2.24 ($7,984)
- 4 Open-market buy Director bought 10,000 shares at an average $2.49 ($24,850)
- 4 Open-market buy Director bought 3,000 shares at an average $2.41 ($7,220)
- 4 Open-market buy Director bought 3,000 shares at an average $2.35 ($7,050)
- 4 Open-market buy Director bought 7,000 shares at an average $2.50 ($17,490)
- 4 Open-market buy Director bought 4,200 shares at $2.38 ($9,996)
- 4 Open-market buy Director bought 5,000 shares at $2.34 ($11,689)
- 4 Open-market buy Director bought 7,000 shares at an average $1.96 ($13,720)
Page 4 of 6 · 115 filings